Medtronic
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medtronic generated cash of $6,787,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$4,450,000,000 last year. Net change in cash is therefore -$259,000,000.
Cash Flow
| 2016 | 5.21B | 2.24B | -9.54B |
|---|---|---|---|
| 2018 | 4.68B | 5.85B | -11.95B |
| 2020 | 7.23B | -3.20B | -4.19B |
| 2021 | 6.24B | -2.86B | -4.13B |
| 2023 | 6.03B | -3.49B | -4.96B |
| 2024 | 6.78B | -2.36B | -4.45B |
0Y6X.L Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 1.54B | 3.71B | 4.14B | 4.39B | 4.96B | 4.84B |
Operating activities | ||||||
Net income | 3.67B | 3.75B | 3.60B | 4.78B | 3.10B | 3.53B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.64B | 2.69B | 2.70B | 2.66B | 2.64B | 2.82B |
Stock-based compensation expense | 393M | 355M | 345M | 297M | 344M | 375M |
| Deferred income tax benefit | 393M | 355M | 345M | 297M | 344M | 375M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -391M | -576M | -761M | 1.29B | -275M | -435M |
Inventories | -139M | -939M | 78M | -577M | -192M | -186M |
Accounts payable | 391M | 696M | 531M | -44M | 65M | -379M |
Cash generated by operating activities | 6.78B | 6.03B | 6.24B | 7.23B | 4.68B | 5.21B |
Investing activities | ||||||
Purchases Of Investments | -7.74B | -7.51B | -11.80B | -11.03B | -3.2B | -5.40B |
Investments In Property Plant And Equipment | -1.58B | -1.45B | -1.35B | -1.21B | -1.06B | -1.04B |
Acquisitions Net | -211M | -1.86B | -994M | -488M | 5.92B | -1.21B |
Cash generated by investing activities | -2.36B | -3.49B | -2.86B | -3.20B | 5.85B | 2.24B |
Financing activities | ||||||
Common Stock Issued | 0 | 308M | 474M | 662M | 403M | 491M |
Payments for dividends | -3.66B | -3.61B | -3.12B | -2.89B | -2.49B | -2.13B |
Repurchases of common stock | -2.13B | -645M | -652M | -1.32B | -2.17B | -2.83B |
Repayments of term debt | 0 | -598M | -570M | -542M | -7.34B | -5.12B |
Cash used in financing activities | -4.45B | -4.96B | -4.13B | -4.19B | -11.95B | -9.54B |
Net Change In Cash | -259M | -2.17B | -547M | -253M | -1.29B | -1.96B |
Cash at end of period | 1.28B | 1.54B | 3.59B | 4.14B | 3.66B | 2.87B |
| Data source | Data source | Data source | Data source | Data source | Data source |